MedKoo Cat#: 561608 | Name: Tazanolast

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Tazanolast is a selective mast-cell-stabilizing agent, and inhibits ozone-induced airway hyperresponsiveness.

Chemical Structure

Tazanolast
Tazanolast
CAS#82989-25-1

Theoretical Analysis

MedKoo Cat#: 561608

Name: Tazanolast

CAS#: 82989-25-1

Chemical Formula: C13H15N5O3

Exact Mass: 289.1175

Molecular Weight: 289.29

Elemental Analysis: C, 53.97; H, 5.23; N, 24.21; O, 16.59

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Tazanolast; WP-833; WP 833; WP833;
IUPAC/Chemical Name
Butyl 2-oxo-2-[3-(2H-tetrazol-5-yl)anilino]acetate
InChi Key
XQTARQNQIVVBRX-UHFFFAOYSA-N
InChi Code
InChI=1S/C13H15N5O3/c1-2-3-7-21-13(20)12(19)14-10-6-4-5-9(8-10)11-15-17-18-16-11/h4-6,8H,2-3,7H2,1H3,(H,14,19)(H,15,16,17,18)
SMILES Code
O=C(OCCCC)C(NC1=CC=CC(C2=NNN=N2)=C1)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 289.29 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Igarashi A, Iijima H, Tamura G, Shirato K. Tazanolast inhibits ozone-induced airway hyperresponsiveness in guinea pigs. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1531-5. PubMed PMID: 9603134. 2: Kamei C, Mio M, Yoshida T, Saito Y, Toyoda Y, Tsuriya Y. Effect of an active metabolite of the antiallergic agent tazanolast on histamine release from rat mast cells. Arzneimittelforschung. 1997 Apr;47(4):390-4. PubMed PMID: 9150859. 3: Tominaga T, Watanbe A, Tsuji J, Koda A, Nagai H, Kumazawa Y, Shimada H. Effect of TYB-2285 on antigen-induced accumulation of eosinophils into the peritoneal cavity of rats sensitized with Ascaris suum extract. Gen Pharmacol. 1997 Mar;28(3):411-4. PubMed PMID: 9068982. 4: Nishizawa Y, Yamamoto T, Terada N, Fushiki S, Amakata Y, Nishizawa Y. Effects of antiallergic drugs on the proliferation of estrogen-sensitive mouse Leydig cell line. Anticancer Res. 1996 May-Jun;16(3A):1241-5. PubMed PMID: 8702244. 5: Hashimoto T, Toyoda Y, Matsukawa H, Tsuriya Y, Yanagihara Y. [Effect of tazanolast on platelet activating factor-induced airway hyperresponsiveness in guinea pigs]. Arerugi. 1992 Sep;41(9):1430-3. Japanese. PubMed PMID: 1280089. 6: Hashimoto T, Edanami K, Naito A, Sano K, Fushimi H, Goto M. [Anti-allergic effects of tazanolast [butyl 3'-(1H-tetrazol-5-yl) oxanilate, WP-833] metabolites]. Nihon Yakurigaku Zasshi. 1990 Apr;95(4):159-66. Japanese. PubMed PMID: 1695192.